Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa

Among 397,640 first-time blood donors screened in South Africa during 2012–2015, HIV prevalence was 1.13%, hepatitis B virus prevalence 0.66%, and hepatitis C virus prevalence 0.03%. Findings of note were a high HIV prevalence in Mpumalanga Province and the near absence of hepatitis C virus nationwi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeulen, Marion, Swanevelder, Ronel, Chowdhury, Dhuly, Ingram, Charlotte, Reddy, Ravi, Bloch, Evan M., Custer, Brian S., Murphy, Edward L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572879/
https://www.ncbi.nlm.nih.gov/pubmed/28820374
http://dx.doi.org/10.3201/eid2309.161594
_version_ 1783259580367634432
author Vermeulen, Marion
Swanevelder, Ronel
Chowdhury, Dhuly
Ingram, Charlotte
Reddy, Ravi
Bloch, Evan M.
Custer, Brian S.
Murphy, Edward L.
author_facet Vermeulen, Marion
Swanevelder, Ronel
Chowdhury, Dhuly
Ingram, Charlotte
Reddy, Ravi
Bloch, Evan M.
Custer, Brian S.
Murphy, Edward L.
author_sort Vermeulen, Marion
collection PubMed
description Among 397,640 first-time blood donors screened in South Africa during 2012–2015, HIV prevalence was 1.13%, hepatitis B virus prevalence 0.66%, and hepatitis C virus prevalence 0.03%. Findings of note were a high HIV prevalence in Mpumalanga Province and the near absence of hepatitis C virus nationwide.
format Online
Article
Text
id pubmed-5572879
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-55728792017-09-02 Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa Vermeulen, Marion Swanevelder, Ronel Chowdhury, Dhuly Ingram, Charlotte Reddy, Ravi Bloch, Evan M. Custer, Brian S. Murphy, Edward L. Emerg Infect Dis Dispatch Among 397,640 first-time blood donors screened in South Africa during 2012–2015, HIV prevalence was 1.13%, hepatitis B virus prevalence 0.66%, and hepatitis C virus prevalence 0.03%. Findings of note were a high HIV prevalence in Mpumalanga Province and the near absence of hepatitis C virus nationwide. Centers for Disease Control and Prevention 2017-09 /pmc/articles/PMC5572879/ /pubmed/28820374 http://dx.doi.org/10.3201/eid2309.161594 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Vermeulen, Marion
Swanevelder, Ronel
Chowdhury, Dhuly
Ingram, Charlotte
Reddy, Ravi
Bloch, Evan M.
Custer, Brian S.
Murphy, Edward L.
Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa
title Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa
title_full Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa
title_fullStr Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa
title_full_unstemmed Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa
title_short Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa
title_sort use of blood donor screening to monitor prevalence of hiv and hepatitis b and c viruses, south africa
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572879/
https://www.ncbi.nlm.nih.gov/pubmed/28820374
http://dx.doi.org/10.3201/eid2309.161594
work_keys_str_mv AT vermeulenmarion useofblooddonorscreeningtomonitorprevalenceofhivandhepatitisbandcvirusessouthafrica
AT swanevelderronel useofblooddonorscreeningtomonitorprevalenceofhivandhepatitisbandcvirusessouthafrica
AT chowdhurydhuly useofblooddonorscreeningtomonitorprevalenceofhivandhepatitisbandcvirusessouthafrica
AT ingramcharlotte useofblooddonorscreeningtomonitorprevalenceofhivandhepatitisbandcvirusessouthafrica
AT reddyravi useofblooddonorscreeningtomonitorprevalenceofhivandhepatitisbandcvirusessouthafrica
AT blochevanm useofblooddonorscreeningtomonitorprevalenceofhivandhepatitisbandcvirusessouthafrica
AT custerbrians useofblooddonorscreeningtomonitorprevalenceofhivandhepatitisbandcvirusessouthafrica
AT murphyedwardl useofblooddonorscreeningtomonitorprevalenceofhivandhepatitisbandcvirusessouthafrica
AT useofblooddonorscreeningtomonitorprevalenceofhivandhepatitisbandcvirusessouthafrica

Ejemplares similares